Savvion and Patni partner to deliver BPM-enabled solutions

Savvion® and Patni Life Sciences announced today a strategic partnership to jointly deliver Business Process Management (BPM)-enabled solutions for clinical operations on top of Savvion’s Life Sciences Foundation. Savvion and Patni will apply their expertise and experience to help pharmaceutical, medical device, biotech, and Clinical Research Organizations (CRO) meet the unique business, regulatory, and information technology challenges they face across the drug development life cycle.

Expediting the complex, global regulatory process governing drug trials is a major challenge for life sciences firms. A major obstacle is how to reduce the time to get new drugs to the market while still maintaining the highest quality standards. The partnership between Savvion and Patni meets this challenge by combining Patni’s decades of experience in IT and scientific consulting with Savvion’s fourteen years of experience in optimizing and automating business processes. The outcome of the partnership will help life sciences organizations streamline their drug development and clinical trial operations—all while leveraging their existing information technology infrastructure investments. By optimizing the drug development life cycle, customers will be able to lower the time and cost of delivering compliant, safe, and reliable drugs to the marketplace.

This partnership signifies Savvion’s commitment to this market segment, where the company offers targeted Savvion’s “BPM-enabled” applications that allow you to model, simulate, optimize and execute various collaborative clinical operational processes built on top of its robust and proven BPM platform and Life Sciences Foundation. Patni chose to partner with Savvion because of Savvion’s support for security and life sciences standards as well as the open architecture, frameworks, and business accelerators that are life science industry specific for quick ROI and deployment of clinical operations solutions.

“Drug trial managers face tremendous challenges,” said Roy Devine, Associate VP Consulting Services at Patni. “They must deal with expiring drug patents, dwindling drug pipelines, escalating costs of clinical trials, and increasingly stringent new regulatory guidelines that delay time to market. This new partnership will enhance Patni’s consulting practice by allowing us to offer Savvion’s pioneering BPM technology along with Patni’s regulatory and IT expertise to help our clients remain competitive.”

“Savvion is very excited about this new partnership,” said Pejman Makhfi, Vice President of Solutions at Savvion. “With Patni’s domain expertise in life sciences and Savvion’s track record for automating complex business processes, we can work together to give the drug industry BPM-enabled solutions to easily meet complex and ever-changing regulatory requirements and shorten the time to market for new drugs.”

“Addressing Clinical Trial Challenges and Opportunities with BPM,” a recent webinar in Savvion’s “Process Makes Perfect” series is available here: